# Pharmacaribe

- Location (FDA's records): Bonita Springs, FL
- FDA decisions: 4 (2009–2013): 4 510(k) clearances
- Product codes: NVO (2), CAF (2)
- Predicates its devices cite: 7 (2 its own); citations of its devices by later devices: 5 (2 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Clinical Technologies, Inc.: 1 (https://510kreport.com/company/clinical-technologies)
- Trudell Medical Intl.: 1 (https://510kreport.com/company/trudell-medical-intl)
- Nephron Pharmaceuticals Corp.: 1 (https://510kreport.com/company/nephron-pharmaceuticals)
- Dey Laboratories, Inc.: 1 (https://510kreport.com/company/dey-laboratories)
- Pari Innovative Manufacturers, Inc.: 1 (https://510kreport.com/company/pari-innovative-manufacturers)

## Firms that cite its devices most
- Mankind Pharma Limited: 1 (https://510kreport.com/company/mankind-pharma)
- Nephron Pharmaceuticals Corp.: 1 (https://510kreport.com/company/nephron-pharmaceuticals)
- The Ritedose Corporation: 1 (https://510kreport.com/company/ritedose)

## Its most-cited devices
- K101424: Pharmacaribe Inhaled Saline Solutions (2010), cited by 4
- K091862: Nessi Spacer (2009), cited by 1

## Recent decisions
- K130091: Pulmosal (Mar 13, 2013)
- K101532: Nessi Otc Spacer (Sep 1, 2010)
- K101424: Pharmacaribe Inhaled Saline Solutions (Aug 17, 2010)
- K091862: Nessi Spacer (Nov 20, 2009)

Source page: https://510kreport.com/company/pharmacaribe